PD-188669

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePD-188669
Drug Alias NamePD188669
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue PharmaPfizer Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A